Form D · Other Technology
Q Bio, Inc.
San Carlos, CA · CIK 0002020139
Offering snapshot reported Jul 26, 2024 · SEC filing
- Reported sold
- $27.1M Offering amount: $27.1M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 26, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 26, 2024 | Initial | $27,103,721 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-519879
Source: Form D, filed Jul 26, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Terry Doyle | Director |
| Jeffrey Kaditz | Director, Executive, Promoter |
| Vijay Pande, Ph.D. | Director |
| Clarissa Shen | Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
1411 Industrial Road
San Carlos, CA, 94041
San Carlos, CA, 94041